WallStreetZenWallStreetZen

NYSE: QGEN
Qiagen Nv Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for QGEN

Based on 9 analysts offering 12 month price targets for Qiagen Nv

Min Forecast
$36.00-28.56%
Avg Forecast
$45.22-10.26%
Max Forecast
$55.00+9.15%

Should I buy or sell QGEN stock?

Based on 9 analysts offering ratings for Qiagen Nv.

Buy
Strong Buy
2 analysts 22.22%
Buy
1 analysts 11.11%
Hold
6 analysts 66.67%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although QGEN's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates QGEN as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +5.11% per year. Learn More

Be the first to know when Wall Street analysts revise their QGEN stock forecasts and price targets.

QGEN stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-10-22
lockedlocked$00.00+00.00%2026-10-22
lockedlocked$00.00+00.00%2026-10-06
lockedlocked$00.00+00.00%2026-09-09
lockedlocked$00.00+00.00%2026-08-10
Morgan Stanley
Top 26%
75
Strong BuyUpgrades$42.00-16.65%2026-06-23
Stifel Nicolaus
Top 9%
92
HoldMaintains$36.00-28.56%2026-05-18
TD Cowen
Top 3%
98
HoldMaintains$40.00-20.62%2026-05-07
Citigroup
Top 12%
89
HoldMaintains$38.00-24.59%2026-04-29

1 of 1

Forecast return on equity

Is QGEN forecast to generate an efficient return?

Company
19.45%
Industry
394.64%
Market
179.39%
QGEN's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is QGEN forecast to generate an efficient return on assets?

Company
11.09%
Industry
14.75%
QGEN is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

QGEN earnings per share forecast

What is QGEN's earnings per share in the next 3 years based on estimates from 24 analysts?

Avg 1 year Forecast
$2.51+29.94%
Avg 2 year Forecast
$2.69+39.62%
Avg 3 year Forecast
$2.93+51.64%
QGEN's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

QGEN revenue forecast

What is QGEN's revenue in the next 3 years based on estimates from 24 analysts?

Avg 1 year Forecast
$2.2B+3.7%
Avg 2 year Forecast
$2.3B+8.89%
Avg 3 year Forecast
$2.4B+14.88%
QGEN's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

QGEN earnings growth forecast

How is QGEN forecast to perform vs Diagnostics & Research companies and vs the US market?

Company
14.78%
Industry
18.08%
Market
32.74%
QGEN's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
QGEN's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
QGEN's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

QGEN revenue growth forecast

How is QGEN forecast to perform vs Diagnostics & Research companies and vs the US market?

Company
4.69%
Industry
7.57%
Market
13.16%
QGEN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
QGEN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

QGEN vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
QGEN$50.39$45.22-10.26%Buy
TWST$139.92$153.00+9.35%Buy
ICLR$185.27$180.64-2.50%Buy
GRAL$132.55$119.80-9.62%Buy
RDNT$70.34$86.50+22.97%Strong Buy
View Top Diagnostic & Research Stocks

Qiagen Nv Stock Forecast FAQ

Is Qiagen Nv Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 9 Wall Street analysts covering (NYSE: QGEN) stock is to Buy QGEN stock.

Out of 9 analysts, 2 (22.22%) are recommending QGEN as a Strong Buy, 1 (11.11%) are recommending QGEN as a Buy, 6 (66.67%) are recommending QGEN as a Hold, 0 (0%) are recommending QGEN as a Sell, and 0 (0%) are recommending QGEN as a Strong Sell.

If you're new to stock investing, here's how to buy Qiagen Nv stock.

What is QGEN's earnings growth forecast for 2026-2028?

(NYSE: QGEN) Qiagen Nv's forecast annual earnings growth rate of 14.78% is not forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of 18.08%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 32.74%.

Qiagen Nv's earnings in 2026 is $409,316,000.On average, 24 Wall Street analysts forecast QGEN's earnings for 2026 to be $518,636,228, with the lowest QGEN earnings forecast at $455,996,205, and the highest QGEN earnings forecast at $653,594,561. On average, 24 Wall Street analysts forecast QGEN's earnings for 2027 to be $557,266,655, with the lowest QGEN earnings forecast at $492,475,901, and the highest QGEN earnings forecast at $701,365,592.

In 2028, QGEN is forecast to generate $605,223,807 in earnings, with the lowest earnings forecast at $533,008,897 and the highest earnings forecast at $770,850,728.

What is QGEN's revenue growth forecast for 2026-2028?

(NYSE: QGEN) Qiagen Nv's forecast annual revenue growth rate of 4.69% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 7.57%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.16%.

Qiagen Nv's revenue in 2026 is $2,100,363,000.On average, 24 Wall Street analysts forecast QGEN's revenue for 2026 to be $450,412,578,000, with the lowest QGEN revenue forecast at $429,939,279,000, and the highest QGEN revenue forecast at $465,095,449,000. On average, 24 Wall Street analysts forecast QGEN's revenue for 2027 to be $472,953,887,000, with the lowest QGEN revenue forecast at $447,310,563,000, and the highest QGEN revenue forecast at $492,186,380,000.

In 2028, QGEN is forecast to generate $499,010,813,000 in revenue, with the lowest revenue forecast at $468,404,265,000 and the highest revenue forecast at $524,447,336,000.

What is QGEN's forecast return on assets (ROA) for 2026-2029?

(NYSE: QGEN) forecast ROA is 11.09%, which is lower than the forecast US Diagnostics & Research industry average of 14.75%.

What is QGEN's Price Target?

According to 9 Wall Street analysts that have issued a 1 year QGEN price target, the average QGEN price target is $45.22, with the highest QGEN stock price forecast at $55.00 and the lowest QGEN stock price forecast at $36.00.

On average, Wall Street analysts predict that Qiagen Nv's share price could fall to $45.22 by Oct 22, 2027. The average Qiagen Nv stock price prediction forecasts a potential downside of 10.26% from the current QGEN share price of $50.39.

What is QGEN's Earnings Per Share (EPS) forecast for 2026-2028?

(NYSE: QGEN) Qiagen Nv's current Earnings Per Share (EPS) is $1.93. On average, analysts forecast that QGEN's EPS will be $2.51 for 2026, with the lowest EPS forecast at $2.21, and the highest EPS forecast at $3.16. On average, analysts forecast that QGEN's EPS will be $2.69 for 2027, with the lowest EPS forecast at $2.38, and the highest EPS forecast at $3.39. In 2028, QGEN's EPS is forecast to hit $2.93 (min: $2.58, max: $3.73).

What is QGEN's forecast return on equity (ROE) for 2026-2029?

(NYSE: QGEN) forecast ROE is 19.45%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.